Ordinary Index Rebalancing in the Solactive Transatlantic Healthcare Equity Index | April 2020

In the ordinary rebalance the following composition will be implemented:

ABBVIE INC
AGILENT TECHNOLOGIES INC
ALCON INC
ALLERGAN PLC
AMGEN INC
BECTON DICKINSON AND CO
BIO-RAD LABORATORIES INC
BIO-TECHNE CORP
BIOMERIEUX
BRISTOL-MYERS SQUIBB CO
CHINA BIOLOGIC PRODUCTS HOLD
CHR HANSEN HOLDING AS
COLOPLAST AS CLASS B
DANAHER CORP
DEMANT A/S
DIASORIN SPA
ESSILORLUXOTTICA
EUROFINS SCIENTIFIC SE
FRESENIUS MEDICAL CARE AG & CO KGAA
FRESENIUS SE & CO KGAA
GENMAB A/S
GILEAD SCIENCES INC
GRIFOLS SA CLASS A
INCYTE CORP
INTEGRA LIFESCIENCES HOLDING
JOHNSON & JOHNSON
KONINKLIJKE PHILIPS NV
LONZA GROUP AG
MASIMO CORPORATION
MEDTRONIC PLC
MERCK & CO. INC.
MERCK KGAA
NOVARTIS AG
NOVO NORDISK A/S
NOVOZYMES AS CLASS B
ORION OYJ CLASS B
PERKINELMER INC
PFIZER INC
QUEST DIAGNOSTICS INC
ROCHE HOLDING AG
SANOFI SA
SARTORIUS AG PREF
SARTORIUS STEDIM BIOTECH
SIEMENS HEALTHINEERS AG
SONOVA HOLDING AG
STRAUMANN HOLDING AG
THERMO FISHER SCIENTIFIC INC
UCB SA
WATERS CORP
WEST PHARMACEUTICAL SERVICES INC